Gasdermin D Activation by Iron Overload Amplifies Allergic Airway Inflammation.

Authors

Tianwei Pei, Xiang Li

Published in

FASEB journal : official publication of the Federation of American Societies for Experimental Biology. Volume 40. Issue 20. Pages e72378. Oct 31, 2026.

Abstract

Allergic airway diseases, including asthma and allergic rhinitis, represent a rapidly growing global health crisis. A significant proportion of patients exhibit inadequate responses to standard biological therapies targeting classical T helper Type 2 (Th2) inflammation. Current respiratory research is undergoing a fundamental conceptual transformation, expanding beyond isolated immune cell networks to investigate complex metabolic reprogramming and programmed cell death. This comprehensive review aims to elucidate the emerging role of iron homeostasis imbalance as a critical driver of airway pathology and its specific interaction with atypical structural protein cleavage. While traditional models identify Gasdermin D (GSDMD) as a terminal executioner activated by inflammatory proteases (caspases) in canonical pyroptosis, recent breakthroughs reveal a novel, protease-independent GSDMD cleavage mechanism driven directly by iron overload and severe oxidative stress. This atypical iron-GSDMD axis acts as a crucial intersection node between ferroptosis-like lipid peroxidation and classical pyroptosis. The resulting GSDMD pore formation causes massive physical epithelial barrier destruction and the externalization of danger-associated molecular patterns (DAMPs), IL-1β, and IL-18. This process exponentially amplifies local tissue inflammation, driving both classical Type 2 responses and atypical neutrophilic inflammation, ultimately leading to chronic, irreversible airway remodeling. The novel iron-GSDMD axis fundamentally transforms our understanding of respiratory immunology and offers a compelling mechanistic explanation for refractory clinical presentations. Developing therapeutic interventions that incorporate active immune regulation, metabolic correction via iron modulation, and barrier restoration provides a transformative clinical paradigm for treating severe and treatment-resistant allergic airway diseases.

PMID:
42862658
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.